On May 26, 2023, Minnesota Gov. Tim Walz signed legislation requiring pre-close notification for qualifying healthcare transactions, making Minnesota the latest in a rapidly growing number of states with such requirements. Also in May, the Illinois state legislature enacted a statute that, if signed by Gov. J.B. Pritzker as expected, would require pre-close review of
Supreme Court Clarifies the False Claims Act’s Knowledge Requirement, Eliminating a Potential Defense for Government Contractors and Healthcare Providers Accused of Fraud
On June 1, 2023, the Supreme Court unanimously ruled in favor of whistleblower plaintiffs (referred to as “relators”) in consolidated False Claims Act (“FCA”) cases in a decision that clarified the application of the FCA’s knowledge requirement. In United States ex rel. Schutte v. SuperValu Inc., the Court held that the FCA reaches defendants…
Notable Litigation – May 2023
Notable litigation filed during May 2023 includes: (1) SEC v. Bartlett; (2) SEC v. Griffin; (3) Warrow v. Turnipseede; and (4) Commodity Future Trading Commission v. Galles.
SEC v. Bartlett, Case No. 8:23-cv-00765 (C.D. Cal.)
The SEC filed suit against defendant schemers in California federal court for an alleged scheme…
Women in PE to Know: Farrah Holder
McGuireWoods has long been an avid supporter of the advancement of professional women. As part of our initiative seeking to expand the leadership of women in private equity, we are continuing our series of profiling women leaders in private equity. We are hopeful that this series will serve to inspire other women to pursue their…
A View From the Top: Bill Drehkoff of Heart & Vascular Partners
The interview below is part of a McGuireWoods series featuring interviews with C-suite leadership of private equity-backed portfolio companies. To recommend a leader for a future interview, email Holly Buckley at hbuckley@mcguirewoods.com or Tim Fry at tfry@mcguirewoods.com.
Bill Drehkoff is the chief executive officer of Heart & Vascular Partners (HVP), a management services organization…
Healthcare & Life Sciences Private Equity Deal Tracker: Trinity Hunt Acquires Centricity Research
Trinity Hunt Partners has announced it has made a majority investment in Centricity Research.
Centricity, with its U.S. headquarters in Columbus, Ga., is clinical research services provider. Founded in 2007, the company specializes in conducting Phase I-IV clinical trials across more than 40 therapeutic areas
Trinity Hunt, based in Dallas, is a growth-oriented…
New York Pharmacy Owners Indicted for Alleged Healthcare Fraud Scheme
On May 2, the U.S. Department of Justice announced the indictment of two New York state pharmacy owners for their participation in an alleged $29 million healthcare fraud scheme. They face charges of conspiracy to commit healthcare fraud, conspiracy to commit money laundering and conspiracy to pay illegal healthcare kickbacks and bribes.
Read on for…
Healthcare & Life Sciences Private Equity Deal Tracker: TA Invests in Alpha II
TA Associates has announced it will make a growth investment in Alpha II.
Alpha II, based in Tallahassee, Fla., is a provider of healthcare revenue cycle management technology solutions. Founded in 1983, the company works with providers across the care continuum.
TA, based in Boston, considers a range of investment types, from minority…
Crafting Successful Healthcare Investments: The Power of the Right Partners and Assets
On this episode of Across the Table, host Kayla McCann Marty is joined by Alexis Rathborne, Managing Director of Investments at Trident, for a discussion on the healthcare market and the investment thesis driving Trident’s team. Alexis explains how she applies Trident’s investment thesis — that identifying the right investment and operating partners is…
GTCR Closes New Fund With $11.5 Billion
GTCR has announced it has closed its latest fund with $11.5 billion in commitments.
It includes total limited partner commitments of $11 billion and a commitment from GTCR of approximately $500 million.
The new fund, GTCR Fund XIV, had an initial target of $9.25 billion.
GTCR, based in Chicago, pursues a wide range of…